The synthesis of tirzepatide was initial disclosed in patents filed by Eli Lilly and Company in 2016.[36] This takes advantage of typical solid period peptide synthesis, having an allyloxycarbonyl guarding group on the lysine at posture twenty in the linear chain of amino acids, enabling a closing set of https://corepepptides.com/product/tirzepatide-10mg/